Lupron suppression before embryo transfer with endometriosis?

Lupron (a GnRH agonist) before a frozen embryo transfer is sometimes used to “quiet” endometriosis activity by deeply suppressing estrogen for a short period of time. For some patients—especially those with significant symptoms, suspected active inflammation, adenomyosis, or prior transfer failures—this kind of suppression can be part of an IVF plan aimed at improving the uterine/pelvic environment before transfer. The trade-off is that Lupron doesn’t remove endometriosis lesions or “cure” the disease; it’s symptom- and activity-suppressing, and symptoms commonly return after stopping.

The decision is very individual because the downsides can be real: hot flashes, sleep disruption, mood changes, vaginal dryness, and bone density effects (which is why these medications are typically used only short-term, sometimes with add-back therapy). If you’re considering Lupron specifically as a bridge to embryo transfer, it’s worth zooming out and looking at the bigger strategy—whether you may benefit more from addressing disease at its root (often via expert excision, when appropriate), versus proceeding with a time-limited suppression approach to optimize timing for transfer. Our team can help you weigh your endometriosis history, imaging, symptoms, and fertility timeline so your plan supports both pregnancy goals and long-term health—reach out to schedule a consultation if you’d like us to review your case.